Novel irreversible covalent BTK inhibitors discovered using DNA-encoded chemistry
Open Access
- 1 July 2021
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 42, 116223
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Afatinib: First Global ApprovalDrugs, 2013
- Structure–kinetic relationship study of CDK8/CycC specific compoundsProceedings of the National Academy of Sciences, 2013
- Insights into the conformational flexibility of Bruton's tyrosine kinase from multiple ligand complex structuresProtein Science, 2010
- Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritisNature Chemical Biology, 2010
- Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinasesProtein Science, 2010
- XDSActa Crystallographica Section D Structural Biology, 2010
- Design, synthesis and selection of DNA-encoded small-molecule librariesNature Chemical Biology, 2009
- Discovery of N-(2-Chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical AssaysJournal of Medicinal Chemistry, 2004
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- The CCP4 suite: programs for protein crystallographyActa Crystallographica Section D Structural Biology, 1994